Ziprasidone for severe conduct and other disruptive behavior disorders in children and adolescents - a placebo controlled, randomized, double blind clinical trial

Trial Profile

Ziprasidone for severe conduct and other disruptive behavior disorders in children and adolescents - a placebo controlled, randomized, double blind clinical trial

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Jun 2011

At a glance

  • Drugs Ziprasidone (Primary)
  • Indications Behavioural disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Nov 2008 Investigator names updated.
    • 10 Nov 2008 Planned number of patients changed from 50 to 51.
    • 10 Nov 2008 Status changed from recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top